Waltham, Massachusetts–based BVI designed Leos for a more intuitive laser endoscopic cyclophotocoagulation (ECP) procedure. It aims to integrate seamlessly into the surgical workflow while treating glaucoma.

The company says Leos is the only laser system that lowers intraocular pressure by addressing aqueous humor production in a minimally invasive ab interno procedure. It incorporates unique endoscopic capabilities to provide superior visualization of the eye anatomy. According to a news release, this level of visualization hasn’t been seen in the past or with the latest imaging technology.

BVI Medical VP of Global R&D, Mikhail Boukhny, said the company sought to create a system that enhances the surgical experience. Boukhny said the company wanted to deliver a novel, effective treatment with intuitiveness, precision and ease of use.